Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05880368 · ClinicalTrials.gov registry record · NA
Partnership in Resilience for Medication Safety (PROMIS)
A NA study of Patient Engagement and Patient Empowerment, sponsored by The University of Texas at Arlington.
- Completed
- Registry status
- NA
- Development phase
- 405
- Enrollment target
- 2
- Study locations
NCT05880368: Completed NA study of Patient Engagement and Patient Empowerment, sponsored by The University of Texas at Arlington.
NCT05880368 is a NA study of Patient Engagement and Patient Empowerment that has completed, run by The University of Texas at Arlington. The registered enrollment target is 405 participants, above the 322-participant average among 6 other Patient Engagement trials with a reported enrollment target (26% higher). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05880368, a NA study of Patient Engagement and Patient Empowerment, has completed, sponsored by The University of Texas at Arlington.
- COMPLETED
- Registry status
- NA
- Development phase
- 405 participants
- Enrollment target
- 2
- Study locations
Study Summary
The trial is to assess the impact of two patient partnership tools: (1) a one-page 'visit prep guide' given to relevant patients by clinic staff before seeing the provider, with the intention to improve communication and shared decision-making; and (2) a series of short educational videos that clinic staff can encourage patients to watch.
Primary Outcome
Medication use and self-efficacy, which is a validated 8-item, 4-point Likert scale survey with a score range of 8-32 and higher indicating higher self-efficacy. The items are: (1) It is easy for me to take my medicine on time, (2) It is easy to remember to take all my medicines, (3) It is easy for me to set a schedule to take my medicines each day, (4) It is easy for me to take my medicines each day, (5) It is easy for me to ask my pharmacist questions about my medicine, (6) It is easy for me t
Conditions Studied
Interventions
- OTHER Patient partnership tools
Study Locations (2)
Texas
- Texas Health Care - Fort Worth
- John Peter Smith Health - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2023-06-26 |
| Est. Completion | 2025-07-30 |
| Phase | NA |
What the finished NCT05880368 record still lists
NCT05880368 is an interventional study that assigns participants to a tested intervention. The registered 405 participants enrollment target is mid-sized for trials with a published cap, above the 322-participant average among 6 other Patient Engagement trials with a reported enrollment target (26% higher).
The record links to 3 conditions, with Patient Engagement appearing as the primary indexed condition, and to 1 intervention - of which Patient partnership tools is the first listed.
NCT05880368 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05880368 about?
NCT05880368 is a clinical study titled "Partnership in Resilience for Medication Safety (PROMIS)". The trial is to assess the impact of two patient partnership tools: (1) a one-page 'visit prep guide' given to relevant patients by clinic staff before seeing the provider, with the intention to improve communication and shared decision-making; and (2) a series of short educational videos that clini...
What is the current status of trial NCT05880368?
This trial is currently completed. It is a NA study. The enrollment target is 405 participants. The study started on 2023-06-26. Estimated completion is 2025-07-30.
What conditions does trial NCT05880368 study?
This clinical trial studies the following conditions: Patient Engagement, Patient Empowerment, Patient Activation.
What interventions are being tested in trial NCT05880368?
The interventions under investigation include: Patient partnership tools (OTHER).
Who is sponsoring clinical trial NCT05880368?
This trial is sponsored by The University of Texas at Arlington, which has 32 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05880368 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patient Engagement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disorders of Pregnancy
RECRUITING · NA
-
Melanated Group Midwifery Care (MGMC)
RECRUITING · NA
-
Virtual and Video Counseling Versus In-Office Counseling for Laparoscopic Hysterectomy
ACTIVE NOT RECRUITING · NA
-
Self-Management and Glycemic Control in Adult Haitian Immigrants With Type 2 Diabetes
ACTIVE NOT RECRUITING · NA
-
Evaluating the Impact of a Supportive Care Program
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05576350 · 405 participants · NA
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
- NCT07066657 · 405 participants · Phase 1
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI